Senators Push For Tighter Regulations Regarding Antipsychotics in Nursing Homes

Three US senators have banded together to curb the over use of powerful sedatives, known as antipsychotics, in nursing homes. The three have proposed that federal regulators be required to issue mandatory rules for nursing homes to follow in seeking permission from patients, or their designated health care agents, such as a family member, before administering antipsychotics for any off-label use.

The Food and Drug Administration (FDA) has approved uses for antipsychotics including schizophrenia, however, physicians are allowed to prescribe antipsychotics  for other illnesses not approved by the FDA.
These "off label" uses have proven to be both harmful and ineffective when prescribed to frail dementia patients.

Yet, federal data show that roughly 185,000 nursing home residents in the United States received antipsychotics in 2010. The proposal by the senators would mandate that nursing homes provide information about the risks and side effects before administering antipsychotics for off-label use. For more, read the story.

Robert W. Carter, Jr. is a Virginia attorney whose law practice is dedicated to protecting the rights of the victims of nursing home and assisted living neglect and abuse in Richmond, Roanoke, Norfolk, Lynchburg, Danville, Charlottesville, and across Virginia.

No comments (Add your own)

Add a New Comment


Comment Guidelines: No HTML is allowed. Off-topic or inappropriate comments will be edited or deleted. Thanks.